CIK 0001175680 · Non-accelerated filer<br>Smaller reporting company
CytoDyn Inc.
Sign in to watch- Ticker
- CYDY
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- May 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 753056237
- Phone
- 360-980-8524
- Business address
- 1111 MAIN STREET, SUITE 660, VANCOUVER, WA, 98660
- Former names
- CYTODYN INC, REXRAY CORP
- DEFA14A Proxy Proxy Materials
- 8-K Event Other events
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- DFAN14A Other Proxy Soliciting Materials
- DEFA14A Proxy Proxy Materials
- 8-K Event Other events
- DFAN14A Other Proxy Soliciting Materials
- DEFC14A Other DEFC14A
- DFAN14A Other Proxy Soliciting Materials
- DEFA14A Proxy Proxy Materials
- 8-K Event Other events
- DFAN14A Other Proxy Soliciting Materials
- PRRN14A Other PRRN14A
- DFAN14A Other Proxy Soliciting Materials
- 4 Grant or award President & CEO acquired 275,758 shares (grant or award)
- 4 Grant or award Chairman & CMO acquired 194,011 shares (grant or award)
- 4 Grant or award Chief Technology Officer acquired 87,301 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 3,023 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 19,384 shares (grant or award)
Page 20 of 71 · 1,401 filings